Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sutter Securities Group is a U.S. financial services and investment banking company, not a biotech or healthcare operating company. Founded in 2013 and headquartered in Irvine, California, it owns and operates a set of regulated capital-markets subsidiaries including broker-dealer, clearing, transfer agent, funding portal, and investment management businesses. The company is best known for its FlashFunders online securities platform, which is designed to support capital formation across Regulation D, Regulation A+, Regulation S, Regulation CF, and registered IPO offerings. Sutter Securities Group appears to operate as part of the Boustead organization and has been described as a majority-owned subsidiary of Boustead & Company Limited following its sale to Boustead in 2017. While it may advise clients in life sciences among other sectors, it is not itself a life science, biotech, pharma, or healthcare developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sutter Securities Group.